Carisma Therapeutics Inc. (NASDAQ: CARM)
$1.34
+0.0800 ( +6.35% ) 334.2K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$1.34
Previous close
$1.26
Volume
334.2K
Market cap
$55.67M
Day range
$1.25 - $1.38
52 week range
$0.99 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 67 | Nov 09, 2023 |
8-k | 8K-related | 35 | Sep 01, 2023 |
10-q | Quarterly Reports | 63 | Aug 10, 2023 |
8-k | 8K-related | 14 | Aug 10, 2023 |